Skip to ContentSkip to Navigation
How to find us prof. dr. E.P. (Eugène) van Puijenbroek

prof. dr. E.P. (Eugène) van Puijenbroek

Professor of Pharmacovigilance
prof. dr. E.P. (Eugène) van Puijenbroek
Netherlands Pharmacovigilance Centre Lareb:
+31 73 646 9700 (Secretariaat)


Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry

Body weight gain in clozapine-treated patients: Is norclozapine the culprit?

Comparative Assessment of the Pharmacovigilance Systems within the Neglected Tropical Diseases Programs in East Africa-Ethiopia, Kenya, Rwanda, and Tanzania

COVID-19 tijdens zwangerschap en borstvoeding

Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?

Efficacy, Safety, and Economics of Innovative Medicines: The Role of Multi-Criteria Decision Analysis and Managed Entry Agreements in Practice and Policy

Gastrointestinal adverse drug reaction profile of etanercept: real world data from patients and healthcare professionals

Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review

Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels-A prospective pharmacokinetic study

Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?

Read more


Authors of Highly Criticized COVID-19 Vaccine Study Defend It

Hoe weet je of een depressie het gevolg is van medicatie?